Nektar Therapeutics
NKTR
#4702
Rank
NZ$3.45 B
Marketcap
NZ$123.48
Share price
-0.15%
Change (1 day)
457.00%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$13.62

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$13.37. In 2024 the company made an earnings per share (EPS) of NZ-$14.86 an increase over its 2023 EPS that were of NZ-$36.73.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$13.62-8.36%
2024NZ-$14.86-59.54%
2023NZ-$36.73-25.89%
2022NZ-$49.56-31.12%
2021NZ-$71.9614.86%
2020NZ-$62.65-1.19%
2019NZ-$63.40-163.96%
2018NZ$99.13-725.4%
2017NZ-$15.85-42.73%
2016NZ-$27.6883.33%
2015NZ-$15.1039.53%
2014NZ-$10.82-69.29%
2013NZ-$35.22-6.67%
2012NZ-$37.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.68-239.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.28-117.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.04-279.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$1.11-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.26-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$8.97-167.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.12-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.47-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland